Article
In vivo challenges of anti-diabetic peptide therapeutics: Gastrointestinal stability, toxicity and allergenicity
2020-11-01
Abstract excerpt
A plethora of research has explored the potential of bioactive peptide as a new class of drug therapeutics, yet only a minute amount has successfully translated into clinical trials. Possible reasons may include several in vivo challenges such as the poor peptide bioavailability upon oral ingestion, peptide toxicity and peptide allergenicity. Bioinformatics offers a preliminary in silico prediction, screening and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 616f4778-ff33-5d52-abd0-10941413b0b5
- DOI
- 10.1016/j.tifs.2020.09.005
